Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Tony K. L. Kiang & Mary H. H. Ensom. (2016) Therapeutic drug monitoring of mycophenolate in adult solid organ transplant patients: an update. Expert Opinion on Drug Metabolism & Toxicology 12:5, pages 545-553.
Read now
Read now
Bernardino Marcos, Lorena Bouzas & J. Carlos Tutor. (2011) A limited sampling strategy for estimation of the area under the curve (0 to 8 hours) of mycophenolic acid administered three times daily to liver transplant recipients. Upsala Journal of Medical Sciences 116:1, pages 47-51.
Read now
Read now
Articles from other publishers (17)
Kun Shao, Yichen Jia, Jiaqian Lu, Wei Zhang, Bing Chen, Dehua Chen, Huimin An, Quan Zhou, Ruiming Rong, Tongyu Zhu & Peijun Zhou. (2022) Estimation of Mycophenolic Acid Exposure in Chinese Renal Transplant Patients by a Joint Deep Learning Model. Therapeutic Drug Monitoring 44:6, pages 738-746.
Crossref
Crossref
Joanna Sobiak & Matylda Resztak. (2021) A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration–Time Curve Estimation. European Journal of Drug Metabolism and Pharmacokinetics 46:6, pages 721-742.
Crossref
Crossref
Joanna Sobiak, Matylda Resztak, Maria Chrzanowska, Jacek Zachwieja & Danuta Ostalska-Nowicka. (2021) The Evaluation of Multiple Linear Regression–Based Limited Sampling Strategies for Mycophenolic Acid in Children with Nephrotic Syndrome. Molecules 26:12, pages 3723.
Crossref
Crossref
Hongping Xiang, Hong Zhou, Jing Zhang, Yongfeng Sun, Yirong Wang, Yong Han & Jie Cai. (2021) Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients. Frontiers in Pharmacology 12.
Crossref
Crossref
Iona Berger, Kathryn Haubrich, Mary H. H. Ensom & Roxane Carr. (2019) RELATE: Relationship of limited sampling strategy and adverse effects of mycophenolate mofetil in pediatric renal transplant patients. Pediatric Transplantation 23:2, pages e13355.
Crossref
Crossref
W. Cai, Q. Cai, N. Xiong, Y. Qin, L. Lai, X. Sun & Y. Hu. (2018) Limited Sampling Strategy for Estimating Mycophenolic Acid Exposure on Day 7 Post-Transplant for Two Mycophenolate Mofetil Formulations Derived From 20 Chinese Renal Transplant Recipients. Transplantation Proceedings 50:5, pages 1298-1304.
Crossref
Crossref
P. Marquet & A. Åsberg. 2017. Individualized Drug Therapy for Patients. Individualized Drug Therapy for Patients
255
279
.
S. Yamada, H. Shiohira, H. Uehara, N. Hokama, S. Saitou & Y. Ooshiro. (2016) Implications of Clinical Mycophenolate Mofetil Dose According to Individual Body Weight in Japanese Renal Transplant Recipients. Transplantation Proceedings 48:1, pages 35-41.
Crossref
Crossref
Nayoung Han, Hwi-yeol Yun, In-Wha Kim, Yoon Jung Oh, Yon Su Kim & Jung Mi Oh. (2014) Population pharmacogenetic pharmacokinetic modeling for flip-flop phenomenon of enteric-coated mycophenolate sodium in kidney transplant recipients. European Journal of Clinical Pharmacology 70:10, pages 1211-1219.
Crossref
Crossref
Christine E. Staatz & Susan E. Tett. (2014) Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Archives of Toxicology 88:7, pages 1351-1389.
Crossref
Crossref
Azrin N. Abd Rahman, Susan E. Tett & Christine E. Staatz. (2014) How Accurate and Precise Are Limited Sampling Strategies in Estimating Exposure to Mycophenolic Acid in People with Autoimmune Disease?. Clinical Pharmacokinetics 53:3, pages 227-245.
Crossref
Crossref
Hyeyoung KimNam-Joon YiJuyeun LeeJoohyun KimMi-Ra MoonJaehong JeongJeong-Moo LeeTae Suk YouSuk-Won SuhMin-Su ParkYoungRok ChoiGeun HongHae Won LeeKwang-Woong LeeKyung-Suk Suh. (2014) Safety of reduced dose of mycophenolate mofetil combined with tacrolimus in living-donor liver transplantation. Clinical and Molecular Hepatology 20:3, pages 291.
Crossref
Crossref
Ana I. Sánchez Fructuoso, Isabel Perez-Flores, Natividad Calvo, Rosalia Valero, Elisa Matilla, Dolores Ortega, Maria A. Del Dedo, Cristina Fernández-Pérez & Alberto Barrientos. (2012) Limited-Sampling Strategy for Mycophenolic Acid in Renal Transplant Recipients Reciving Enteric-Coated Mycophenolate Sodium and Tacrolimus. Therapeutic Drug Monitoring 34:3, pages 298-305.
Crossref
Crossref
Christine E. Staatz & Susan E. Tett. (2011) Maximum A Posteriori Bayesian Estimation of Mycophenolic Acid Area Under the Concentration-Time Curve: Is This Clinically Useful for Dosage Prediction Yet?. Clinical Pharmacokinetics 50:12, pages 759-772.
Crossref
Crossref
Natalia Lampón, María J. Tutor-Crespo, Rafael Romero & José C. Tutor. (2011) Diagnostic efficiency of truncated area under the curve from 0 to 2 h (AUC0–2) of mycophenolic acid in kidney transplant recipients receiving mycophenolate mofetil and concomitant tacrolimus. Clinical Chemistry and Laboratory Medicine 49:7.
Crossref
Crossref
Michael C. Milone & Leslie M. J. Shaw. 2010. Immunotherapy in Transplantation. Immunotherapy in Transplantation
95
113
.
Mai Al-Khatib, R Jean Shapiro, Nilufar Partovi, Lillian SL Ting, Marc Levine & Mary HH Ensom. (2010) Limited Sampling Strategies for Predicting Area Under the Concentration-Time Curve of Mycophenolic Acid in Islet Transplant Recipients. Annals of Pharmacotherapy 44:1, pages 19-27.
Crossref
Crossref